title: [Update on vitrectomy for pediatric uveitis].
abstract: OBJECTIVE
  The role of vitrectomy in pediatric uveitis has as yet not been established. Addressing this question has been reinforced since the recent introduction of the new and relatively well tolerated medical treatment options using biologicals, i. e. TNFalpha blocking agents.
  
  
  METHODS
  A systematic review of literature has been supplemented by results of vitrectomy performed in 41 consecutive eyes of 33 children and adolescents at our institution and followed for 0.5 to 10 years.
  
  
  RESULTS
  No single controlled study on the role of vitrectomy for uveitis has been identified. Beyond a total of 44 case series including 1762 eyes within the last 25 years, 3 papers specifically focussed on vitrectomy for pediatric uveitis including 73 eyes. This series included 29 eyes of our series. Published and recent own data indicate 2 specific findings consistent for all series: reduction of CME presence from 36 to 6.9% with a resulting visual improvement in 79.1% of cases and a quietening down of inflammatory activity postoperatively allowing to taper down or stop steroid and immunosuppressive therapy from preoperatively 80 and 30% to approximately 30 and 10%, respectively.
  
  
  CONCLUSIONS
  In the absence of evidence-based results, the data from case series indicate that vitrectomy for pediatric uveitis at least meets the expectations from vitrectomy in adult forms of uveitis regarding the reduction of cystoid macular edema and required systemic steroid and immunosuppressive therapies.
authors.affiliation: Swiss Eye Institute, Bern, Schweiz. justus.garweg@swiss-eye-institute.com
authors.forename: J G
authors.initials: JG
authors.lastname: Garweg
authors.forename: M
authors.initials: M
authors.lastname: Becker
authors.forename: A
authors.initials: A
authors.lastname: Lommatzsch
authors.forename: K U
authors.initials: KU
authors.lastname: Bartz-Schmidt
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D020127:Recovery of Function; D016896:Treatment Outcome; D014605:Uveitis / Q000453:epidemiology* / Q000601:surgery*; D014786:Vision Disorders / Q000453:epidemiology* / Q000517:prevention & control*; D014821:Vitrectomy / Q000706:statistics & numerical data*